American Alpha Advisors’s Bristol-Myers Squibb BMY Stock Holding History

American Alpha Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$650K	Buy	11,283 +15	+0.1%	+$861	0.35%	48
2026 Q1	$683K	Buy	11,268 +374	+3%	+$21.8K	0.36%	46
2025 Q4	$588K	Buy	10,894 +1,375	+14%	+$66.1K	0.35%	49
2025 Q3	$429K	Buy	9,519 +41	+0.4%	+$1.92K	0.3%	60
2025 Q2	$439K	Buy	9,478 +1,023	+12%	+$50.2K	0.34%	55
2025 Q1	$516K	Sell	8,455 -666	-7%	-$38.8K	0.43%	38
2024 Q4	$516K	Sell	9,121 -599	-6%	-$33.5K	0.45%	32
2024 Q3	$503K	Buy	+9,720	New	+$456K	0.46%	32

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

American Alpha Advisors's BMY Position: Q2 2026 in Review

American Alpha Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.13% in Q2 2026, buying an estimated $861 and bringing the position to 11,283 shares worth $650K. The position accounts for 0.35% of the portfolio, ranked #48.

American Alpha Advisors first reported a position in BMY in Q3 2024 and has held it in 8 quarters since. The position peaked at $683K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

American Alpha Advisors held 11,283 shares of Bristol-Myers Squibb worth $650K as of Q2 2026.
American Alpha Advisors bought 15 Bristol-Myers Squibb shares in Q2 2026, an estimated $861.
Bristol-Myers Squibb made up 0.35% of American Alpha Advisors's portfolio in Q2 2026, its #48 holding.
American Alpha Advisors first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 8 quarters since.
American Alpha Advisors's Bristol-Myers Squibb position peaked at $683K in Q1 2026.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on American Alpha Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.